These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 9166544)
41. Tempol, one of nitroxides, is a novel ultraviolet-A1 radiation protector for human dermal fibroblasts. Yan SX; Hong XY; Hu Y; Liao KH J Dermatol Sci; 2005 Mar; 37(3):137-43. PubMed ID: 15734282 [TBL] [Abstract][Full Text] [Related]
42. The PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alopecia areata. Behrens-Williams SC; Leiter U; Schiener R; Weidmann M; Peter RU; Kerscher M J Am Acad Dermatol; 2001 Feb; 44(2):248-52. PubMed ID: 11174382 [TBL] [Abstract][Full Text] [Related]
43. Studies of structure-activity relationship of nitroxide free radicals and their precursors as modifiers against oxidative damage. Krishna MC; DeGraff W; Hankovszky OH; Sár CP; Kálai T; Jeko J; Russo A; Mitchell JB; Hideg K J Med Chem; 1998 Aug; 41(18):3477-92. PubMed ID: 9719601 [TBL] [Abstract][Full Text] [Related]
44. Treatment of alopecia areata in the DEBR model using Cyclosporin A lipid vesicles. Verma DD; Verma S; McElwee KJ; Freyschmidt-Paul P; Hoffman R; Fahr A Eur J Dermatol; 2004; 14(5):332-8. PubMed ID: 15358573 [TBL] [Abstract][Full Text] [Related]
45. Protection from photodamage by topical application of caffeine after ultraviolet irradiation. Koo SW; Hirakawa S; Fujii S; Kawasumi M; Nghiem P Br J Dermatol; 2007 May; 156(5):957-64. PubMed ID: 17388926 [TBL] [Abstract][Full Text] [Related]
47. Evaluation of the radioprotective effect of Liv 52 in mice. Jagetia GC; Ganapathi NG; Venkatesh P; Rao N; Baliga MS Environ Mol Mutagen; 2006 Aug; 47(7):490-502. PubMed ID: 16758471 [TBL] [Abstract][Full Text] [Related]
48. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Barker JL; Garden AS; Ang KK; O'Daniel JC; Wang H; Court LE; Morrison WH; Rosenthal DI; Chao KS; Tucker SL; Mohan R; Dong L Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):960-70. PubMed ID: 15234029 [TBL] [Abstract][Full Text] [Related]
49. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204 [TBL] [Abstract][Full Text] [Related]
50. Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin. Tang L; Cao L; Sundberg JP; Lui H; Shapiro J Exp Dermatol; 2004 Jan; 13(1):5-10. PubMed ID: 15009110 [TBL] [Abstract][Full Text] [Related]
51. Amelioration of early radiation effects in oral mucosa (mouse) by intravenous or subcutaneous administration of amifostine. Fleischer G; Dörr W Strahlenther Onkol; 2006 Oct; 182(10):567-75. PubMed ID: 17013569 [TBL] [Abstract][Full Text] [Related]
52. Protection from radiation-induced chromosomal aberrations by the nitroxide Tempol. Johnstone PA; DeGraff WG; Mitchell JB Cancer; 1995 May; 75(9):2323-7. PubMed ID: 7712443 [TBL] [Abstract][Full Text] [Related]
53. Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice. Paus R; Schilli MB; Handjiski B; Menrad A; Henz BM; Plonka P Cancer Res; 1996 Oct; 56(19):4438-43. PubMed ID: 8813138 [TBL] [Abstract][Full Text] [Related]
54. Inhibition of radiation cataractogenesis by WR-77913. Livesey JC; Wiens LW; Von Seggern DJ; Barlow WE; Arnold AM Radiat Res; 1995 Jan; 141(1):99-104. PubMed ID: 7997522 [TBL] [Abstract][Full Text] [Related]
55. Hair Follicle Damage after 100 mGy Low-Dose Fractionated X-Ray Irradiation and the Protective Effects of TEMPOL, a Stable Nitroxide Radical, against Radiation. Kawabata Y; Fukushige T; Indo HP; Matsumoto KI; Ueno M; Nakanishi I; Chatatikun M; Klangbud WK; Surinkaew S; Tangpong J; Kanekura T; Majima HJ Radiat Res; 2024 Feb; 201(2):115-125. PubMed ID: 38211765 [TBL] [Abstract][Full Text] [Related]
56. Inhibition of x-irradiation-enhanced locomotor recovery after spinal cord injury by hyperbaric oxygen or the antioxidant nitroxide tempol. Hillard VH; Peng H; Das K; Murali R; Moorthy CR; Etlinger JD; Zeman RJ J Neurosurg Spine; 2007 Apr; 6(4):337-43. PubMed ID: 17436923 [TBL] [Abstract][Full Text] [Related]
57. Azelastine: its clinical application for radiation dermatitis. Furusawa M; Baba Y; Murakami R; Yokoyama T; Uozumi H; Nishimura R; Takada C; Takahashi M; Eura M; Ishikawa T Radiat Med; 1996; 14(3):151-4. PubMed ID: 8827810 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector. Hahn SM; Krishna MC; DeLuca AM; Coffin D; Mitchell JB Free Radic Biol Med; 2000 Mar; 28(6):953-8. PubMed ID: 10802227 [TBL] [Abstract][Full Text] [Related]
59. In vivo radioprotection and effects on blood pressure of the stable free radical nitroxides. Hahn SM; DeLuca AM; Coffin D; Krishna CM; Mitchell JB Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):839-42. PubMed ID: 9845107 [TBL] [Abstract][Full Text] [Related]